Key Takeaways
- NICE says that industry plays a crucial role in its projects under the Health Technology Assessment Innovation Lab, a sandbox environment for testing new methods and processes.
- The HTA Lab is looking at a range of projects, including disease-modifying Alzheimer’s therapies.
- NICE selects projects by using horizon scanning to discover “disruptive” therapies that are one to two years away from the HTA process.
Industry participation in an HTA sandbox run by England’s health technology assessment (HTA) institute, NICE, is “really crucial” to ensure that the tool is “asking the right questions and testing...
This was the message from NICE’s senior scientific advisor, Jamie Elvidge, who was speaking at NICE’s annual conference on 27 March about the institute’s HTA Innovation Laboratory (HTA Lab).
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?